World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Immunology 57 3640 3357 250 233 219 10146

Luisa Klotz publications per year

The chart shows the history of publications by Luisa Klotz between 2000 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Luisa Klotz published across 26 years, from 2000 to 2025, averaging 10.7 papers a year. Output peaked at 30 publications in 2021. 38 of the 277 publications appeared in the last two years.

No. of publications
10 20 30
Bar chart. Horizontal axis: year, 2000 to 2025. Vertical axis: number of publications, 0 to 30. Peak 30 publications in 2021. 2000: 2 publications 2001: 0 publications 2002: 0 publications 2003: 1 publication 2004: 0 publications 2005: 4 publications 2006: 5 publications 2007: 7 publications 2008: 1 publication 2009: 4 publications 2010: 2 publications 2011: 3 publications 2012: 5 publications 2013: 9 publications 2014: 7 publications 2015: 14 publications 2016: 22 publications 2017: 14 publications 2018: 19 publications 2019: 22 publications 2020: 23 publications 2021: 30 publications 2022: 23 publications 2023: 22 publications 2024: 16 publications 2025: 22 publications
2000 2025

277 publications in total across all disciplines

View publications per year as a table
Luisa Klotz: publications per year, 2000 to 2025
Year Publications
2000 2
2001 0
2002 0
2003 1
2004 0
2005 4
2006 5
2007 7
2008 1
2009 4
2010 2
2011 3
2012 5
2013 9
2014 7
2015 14
2016 22
2017 14
2018 19
2019 22
2020 23
2021 30
2022 23
2023 22
2024 16
2025 22
Total 277
Download as CSV

Luisa Klotz publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Luisa Klotz sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 76 bars. Horizontal axis: publications, 62–71 to 807+. Vertical axis: number of scientists, 0 to 189. Most scientists, 189, have 152–161 publications. The last bar groups every scientist with 807 publications or more. The highlighted bar, 212–221 publications, is where this scientist sits. 62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientist 807+ publications: 100 scientists
62–71 publications 807+

This scientist: 219 publications — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

View publications distribution as a table
Number of Immunology scientists by publication count, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
Publications Scientists This scientist
62–71 9
72–81 23
82–91 40
92–101 72
102–111 86
112–121 108
122–131 150
132–141 160
142–151 159
152–161 189
162–171 166
172–181 181
182–191 188
192–201 187
202–211 178
212–221 158 219
222–231 168
232–241 159
242–251 160
252–261 148
262–271 116
272–281 125
282–291 115
292–301 111
302–311 95
312–321 97
322–331 97
332–341 99
342–351 96
352–361 69
362–371 76
372–381 71
382–391 71
392–401 62
402–411 54
412–421 41
422–431 63
432–441 53
442–451 31
452–461 42
462–471 40
472–481 29
482–491 34
492–501 30
502–511 23
512–521 41
522–531 29
532–541 28
542–551 16
552–561 18
562–571 18
572–581 17
582–591 17
592–601 17
602–611 19
612–621 13
622–631 12
632–641 11
642–651 16
652–661 9
662–671 5
672–681 13
682–691 12
692–701 6
702–711 6
712–721 9
722–731 9
732–741 6
742–751 11
752–761 10
762–771 7
772–781 12
782–791 7
792–801 5
802–806 1
807+ 100
Download as CSV

Luisa Klotz D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Luisa Klotz sits on this spectrum.

No. of scientists
50 100 150 200
Bar chart with 60 bars. Horizontal axis: D-Index, 40–41 to 157+. Vertical axis: number of scientists, 0 to 201. Most scientists, 201, have 58–59 D-Index. The last bar groups every scientist with 157 D-Index or more. The highlighted bar, 56–57 D-Index, is where this scientist sits. 40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40–41 D-Index 157+

This scientist: 57 D-Index — 28th percentile

28% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

View D-Index distribution as a table
Number of Immunology scientists by D-index, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
D-Index Scientists This scientist
40–41 28
42–43 91
44–45 157
46–47 192
48–49 175
50–51 188
52–53 177
54–55 155
56–57 194 57
58–59 201
60–61 197
62–63 201
64–65 173
66–67 167
68–69 172
70–71 199
72–73 184
74–75 133
76–77 163
78–79 127
80–81 121
82–83 125
84–85 121
86–87 102
88–89 96
90–91 75
92–93 72
94–95 74
96–97 66
98–99 68
100–101 49
102–103 60
104–105 54
106–107 36
108–109 23
110–111 52
112–113 41
114–115 34
116–117 25
118–119 28
120–121 11
122–123 20
124–125 27
126–127 19
128–129 20
130–131 16
132–133 17
134–135 14
136–137 15
138–139 9
140–141 11
142–143 9
144–145 9
146–147 7
148–149 7
150–151 7
152–153 5
154–155 8
156 6
157+ 96
Download as CSV

Overview

Luisa Klotz is affiliated with the University Hospital Münster in Germany and has a prominent publication record in the field of medicine, particularly within neurology and related disciplines. Their research output spans key areas such as pathology and forensic medicine, neurology, immunology, molecular biology, and rheumatology.

Their primary research topics include:

  • Multiple Sclerosis Research Studies
  • Peripheral Neuropathies and Disorders
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Polyomavirus and related diseases
  • Systemic Lupus Erythematosus Research
  • T-cell and B-cell Immunology
  • Rheumatoid Arthritis Research and Therapies

Among recent publications authored or co-authored by Klotz are:

  • Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study (2023, The Lancet Neurology)
  • Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper) (2021, Therapeutic Advances in Neurological Disorders)
  • Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: Diagnosis and differential diagnosis (2023, Journal of Neurology)
  • Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients (2020, Journal of Neuroinflammation)
  • Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management (2023, Journal of Neurology)

Klotz has collaborated frequently with several experts in the neurological field, including:

  • Heinz Wiendl (62 collaborations)
  • Sven G. Meuth (40 collaborations)
  • Friedemann Paul (31 collaborations)
  • Catharina C. Groß (29 collaborations)
  • Stefan Bittner (28 collaborations)

Their work is often published in specialized journals, particularly:

  • Neurology
  • Neurology Neuroimmunology & Neuroinflammation
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Journal of Neurology
  • Journal of Neurology Neurosurgery & Psychiatry

With a total of 235 publications in medicine, Klotz's research covers a broad spectrum but maintains a strong focus on neurological and immunological aspects related to neuroinflammatory disorders and autoimmune diseases.

Best Publications

  • Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice.

    Kerstin Berer;Lisa Ann Gerdes;Egle Cekanaviciute;Xiaoming Jia

  • The nuclear receptor PPAR gamma selectively inhibits Th17 differentiation in a T cell-intrinsic fashion and suppresses CNS autoimmunity.

    Luisa Klotz;Sven Burgdorf;Indra Dani;Kaoru Saijo

  • Sodium chloride promotes pro-inflammatory macrophage polarization thereby aggravating CNS autoimmunity.

    Stephanie Hucke;Melanie Eschborn;Marie Liebmann;Martin Herold

  • Impaired NK-mediated regulation of T-cell activity in multiple sclerosis is reconstituted by IL-2 receptor modulation.

    Catharina C. Gross;Andreas Schulte-Mecklenbeck;Anna Rünzi;Tanja Kuhlmann

  • Dimethyl fumarate treatment alters circulating T helper cell subsets in multiple sclerosis

    Catharina C. Gross;Andreas Schulte-Mecklenbeck;Svenja Klinsing;Anita Posevitz-Fejfár

  • Peroxisome proliferator-activated receptor gamma control of dendritic cell function contributes to development of CD4+ T cell anergy.

    Luisa Klotz;Indra Dani;Frank Edenhofer;Lars Nolden

  • Peroxisome Proliferator-Activated Receptor-γ Modulates the Response of Macrophages to Lipopolysaccharide and Glucocorticoids

    Michael Heming;Sandra Gran;Saskia-L. Jauch;Lena Fischer-Riepe

  • Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients

    Sven Jarius;Hannah Pellkofer;Nadja Siebert;Mirjam Korporal-Kuhnke

  • Proinflammatory Stimulation and Pioglitazone Treatment Regulate Peroxisome Proliferator-Activated Receptor γ Levels in Peripheral Blood Mononuclear Cells from Healthy Controls and Multiple Sclerosis Patients

    Luisa Klotz;Martina Schmidt;Thomas Giese;Magdalena Sastre

  • Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial

    Unknown

  • CD8+ T cell-mediated endotheliopathy is a targetable mechanism of neuro-inflammation in Susac syndrome.

    Catharina C. Gross;Céline Meyer;Urvashi Bhatia;Lidia Yshii

  • Teriflunomide treatment for multiple sclerosis modulates T cell mitochondrial respiration with affinity-dependent effects

    Luisa Klotz;Melanie Eschborn;Maren Lindner;Marie Liebmann

  • Nur77 serves as a molecular brake of the metabolic switch during T cell activation to restrict autoimmunity

    Marie Liebmann;Stephanie Hucke;Kathrin Koch;Melanie Eschborn

  • Higher sensitivity in the detection of inflammatory brain lesions in patients with clinically isolated syndromes suggestive of multiple sclerosis using high field MRI: an intraindividual comparison of 1.5 T with 3.0 T.

    Mike P. Wattjes;Götz G. Lutterbey;Michael Harzheim;Jiirgen Gieseke;Jiirgen Gieseke

  • Blood coagulation factor XII drives adaptive immunity during neuroinflammation via CD87-mediated modulation of dendritic cells

    Kerstin Göbel;Susann Pankratz;Chloi-Magdalini Asaridou;Alexander M. Herrmann

  • Fingolimod treatment promotes regulatory phenotype and function of B cells

    Berit Grützke;Stephanie Hucke;Catharina C. Gross;Martin V. B. Herold

  • Broader Epstein–Barr virus–specific T cell receptor repertoire in patients with multiple sclerosis

    Unknown

  • Complete Epstein-Barr virus seropositivity in a large cohort of patients with early multiple sclerosis.

    Sargis Abrahamyan;Sargis Abrahamyan;Bettina Eberspächer;Muna-Miriam Hoshi;Lilian Aly

  • Risks and risk management in modern multiple sclerosis immunotherapeutic treatment.

    Luisa Klotz;Joachim Havla;Nicholas Schwab;Reinhard Hohlfeld

  • Ocrelizumab Extended Interval Dosing in Multiple Sclerosis in Times of COVID-19.

    Leoni Rolfes;Marc Pawlitzki;Steffen Pfeuffer;Christopher Nelke

  • Salt-dependent chemotaxis of macrophages.

    Silke Müller;Thomas Quast;Agnes Schröder;Stephanie Hucke

  • Alemtuzumab treatment alters circulating innate immune cells in multiple sclerosis

    Catharina C. Gross;Diana Ahmetspahic;Tobias Ruck;Andreas Schulte-Mecklenbeck

  • Immune mechanisms of new therapeutic strategies in multiple sclerosis-A focus on alemtuzumab.

    Luisa Klotz;Sven G. Meuth;Heinz Wiendl

  • CC chemokine receptor 4 is required for experimental autoimmune encephalomyelitis by regulating GM-CSF and IL-23 production in dendritic cells

    Karola Poppensieker;David-Marian Otte;Britta Schürmann;Andreas Limmer

Frequent Co-Authors

Heinz Wiendl
Heinz Wiendl University of Münster
Sven G. Meuth
Sven G. Meuth University of Münster
Catharina C. Gross
Catharina C. Gross University of Münster
Frauke Zipp
Frauke Zipp Johannes Gutenberg University of Mainz
Ralf Gold
Ralf Gold Ruhr University Bochum
Brigitte Wildemann
Brigitte Wildemann University Hospital Heidelberg
Hayrettin Tumani
Hayrettin Tumani University of Ulm
Friedemann Paul
Friedemann Paul Charité - University Medicine Berlin
Martin Stangel
Martin Stangel Hannover Medical School
Percy A. Knolle
Percy A. Knolle Technical University of Munich

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, expanding your educational background through specialized nursing programs can open new career doors. Many professionals transition from roles like Family Nurse Practitioner (FNP) to more acute care-focused positions by enrolling in specialized acnp programs. These programs refine skills essential for managing critical patient cases linked to immune-related conditions.

Accelerated routes are popular among individuals looking to advance quickly. The availability of accelerated NP programs lets students fast-track their nurse practitioner credentials online without compromising quality, ideal for those already holding a bachelor’s degree in another field.

For beginners or those making a career switch, there are online nursing programs for non nurses that provide comprehensive foundational knowledge in nursing along with flexible learning schedules. This is a great way to enter the healthcare field while later specializing in immunology-related areas.

Additionally, some students may find entry easier through easiest absn to get into programs, which offer streamlined admissions and accelerated coursework. These options help prospective nurses establish a strong base before progressing into advanced immunology studies or clinical roles.

Best Scientists Citing Luisa Klotz

Trending Scientists

Recently Published Articles